165 related articles for article (PubMed ID: 32866811)
21. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples.
Jääskeläinen AJ; Kekäläinen E; Kallio-Kokko H; Mannonen L; Kortela E; Vapalahti O; Kurkela S; Lappalainen M
Euro Surveill; 2020 May; 25(18):. PubMed ID: 32400364
[TBL] [Abstract][Full Text] [Related]
22. False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease.
To KK; Chua GT; Kwok KL; Wong JS; Au DCY; Lam YY; Wong WH; Ho MH; Chan GC; Chui CS; Li X; Tung KT; Wong RS; Tso WW; Wong IC; Wong CS; Fong CH; Chan KH; Yuen KY; Ip P; Kwan MY
Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115141. PubMed ID: 32795776
[TBL] [Abstract][Full Text] [Related]
23. Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results.
Wang H; Wiredja D; Yang L; Bulterys PL; Costales C; Röltgen K; Manalac J; Yee J; Zehnder J; Shi RZ; Boyd SD; Pinsky BA
Clin Chem; 2021 Jul; 67(7):977-986. PubMed ID: 33720347
[TBL] [Abstract][Full Text] [Related]
24. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
National SARS-CoV-2 Serology Assay Evaluation Group
Lancet Infect Dis; 2020 Dec; 20(12):1390-1400. PubMed ID: 32979318
[TBL] [Abstract][Full Text] [Related]
25. Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT).
Liu J; Lian R; Zhang G; Hou B; Wang C; Dong J; Yang L; Wang J; Dai S; Chen L; Zhang G; Lu X; Ye T
Ann Med; 2021 Dec; 53(1):34-42. PubMed ID: 32808808
[TBL] [Abstract][Full Text] [Related]
26. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.
Lee CY; Lin RTP; Renia L; Ng LFP
Front Immunol; 2020; 11():879. PubMed ID: 32391022
[TBL] [Abstract][Full Text] [Related]
27. Multiplexed detection and quantification of human antibody response to COVID-19 infection using a plasmon enhanced biosensor platform.
Cady NC; Tokranova N; Minor A; Nikvand N; Strle K; Lee WT; Page W; Guignon E; Pilar A; Gibson GN
Biosens Bioelectron; 2021 Jan; 171():112679. PubMed ID: 33069957
[TBL] [Abstract][Full Text] [Related]
28. A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021.
Abe KT; Rathod B; Colwill K; Gingras AC; Tuite A; Robbins NF; Orjuela G; Jenkins C; Conrod V; Yi QL; O'Brien SF; Drews SJ
Microbiol Spectr; 2022 Jun; 10(3):e0113422. PubMed ID: 35652636
[TBL] [Abstract][Full Text] [Related]
29. Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2.
Auerswald H; Eng C; Lay S; In S; Eng S; Vo HTM; Sith C; Cheng S; Delvallez G; Mich V; Meng N; Sovann L; Sidonn K; Vanhomwegen J; Cantaert T; Dussart P; Duong V; Karlsson EA
Front Med (Lausanne); 2022; 9():864972. PubMed ID: 35602487
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.
Schaffner A; Risch L; Aeschbacher S; Risch C; Weber MC; Thiel SL; Jüngert K; Pichler M; Grossmann K; Wohlwend N; Lung T; Hillmann D; Bigler S; Bodmer T; Imperiali M; Renz H; Kohler P; Vernazza P; Kahlert CR; Twerenbold R; Paprotny M; Conen D; Risch M
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317059
[TBL] [Abstract][Full Text] [Related]
31. Performance estimation of two in-house ELISA assays for COVID-19 surveillance through the combined detection of anti-SARS-CoV-2 IgA, IgM, and IgG immunoglobulin isotypes.
Ramírez-Reveco A; Velásquez G; Aros C; Navarrete G; Villarroel-Espíndola F; Navarrete M; Fica A; Plaza A; Castro N; Verdugo C; Acosta-Jamett G; Verdugo CC
PLoS One; 2023; 18(2):e0270388. PubMed ID: 36745590
[TBL] [Abstract][Full Text] [Related]
32. Standardization of in-house anti-IgG and IgA ELISAs for the detection of COVID-19.
Rungrojcharoenkit K; Suthangkornkul R; Utennam D; Buddhari D; Pinpaiboon S; Mongkolsirichaikul D; Fernandez S; Jones AR; Cotrone TS; Hunsawong T
PLoS One; 2023; 18(6):e0287107. PubMed ID: 37294808
[TBL] [Abstract][Full Text] [Related]
33. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.
Garritsen A; Scholzen A; van den Nieuwenhof DWA; Smits APF; Datema ES; van Galen LS; Kouwijzer MLCE
Infect Dis (Lond); 2021 Jul; 53(7):498-512. PubMed ID: 33684020
[TBL] [Abstract][Full Text] [Related]
34. Optimizing SARS-CoV-2 Immunoassays for Specificity in Dengue-Co-Endemic Areas.
Adnan N; Haq MA; Tisha TA; Khandker SS; Jamiruddin MR; Sajal SSA; Akter S; Ahmed MF; Raqib R; Khondoker MU; Azmuda N; Haque M
Cureus; 2023 Oct; 15(10):e47683. PubMed ID: 37899905
[TBL] [Abstract][Full Text] [Related]
35. Review of Current Advances in Serologic Testing for COVID-19.
Espejo AP; Akgun Y; Al Mana AF; Tjendra Y; Millan NC; Gomez-Fernandez C; Cray C
Am J Clin Pathol; 2020 Aug; 154(3):293-304. PubMed ID: 32583852
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications.
Sulaeman H; Grebe E; Dave H; McCann L; Di Germanio C; Sanghavi A; Sclar V; Bougie DW; Chatelain G; Biggerstaff BJ; Jones JM; Thornburg NJ; Kleinman S; Stone M; Busch MP
Microbiol Spectr; 2023 Aug; 11(4):e0323422. PubMed ID: 37347180
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays.
Wellinghausen N; Voss M; Ivanova R; Deininger S
GMS Infect Dis; 2020; 8():Doc22. PubMed ID: 32983837
[TBL] [Abstract][Full Text] [Related]
38. Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing.
Crawford KHD; Selke S; Pepper G; Goecker E; Sobel A; Wald A; Johnston C; Greninger AL
J Clin Microbiol; 2024 Jun; 62(6):e0026324. PubMed ID: 38687020
[TBL] [Abstract][Full Text] [Related]
39. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements.
Hoschler K; Ijaz S; Andrews N; Ho S; Dicks S; Jegatheesan K; Poh J; Warrener L; Kankeyan T; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Aiano F; Brown KE; Ramsay ME; Brown D; Parry JV; Ladhani SN; Zambon M
Microbiol Spectr; 2022 Feb; 10(1):e0078621. PubMed ID: 34985331
[TBL] [Abstract][Full Text] [Related]
40. Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody.
Moscato G; Mazzetti P; Lucenteforte E; Rosellini A; Cara A; Quaranta P; Mainardi V; Villa P; Focosi D; Lanza M; Bianco I; Mazzoni A; Falcone M; Menichetti F; Maggi F; Lai M; Freer G; Pistello M
J Clin Virol Plus; 2021 Jun; 1(1):100016. PubMed ID: 35262004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
